Selank's benefits include potential support for anxiety regulation, stress resilience, cognitive function, and neurological health, making it a peptide of growing interest in both the scientific community and among followers of research peptides. Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) derived from the naturally occurring immunological peptide tuftsin. Developed in Russia, it has been studied for its potential anxiolytic, nootropic, neuroprotective, and immunomodulatory properties. Unlike many traditional anxiolytic drugs that primarily act on a single neurotransmitter system, Selank appears to influence multiple pathways related to mood, cognitive functions, stress adaptation, and brain function, including GABA signaling, endogenous opioid peptides, neurotrophic factors, and immune system mediators [1–3].
Research suggests that the combination of these mechanisms may support emotional balance, cognitive function, stress resilience, and neurological health without causing significant sedation or risk of dependence [1-3].
To learn basic information about this peptide, it's also worth checking out the main guide: https://bioevidencehub.com/peptyd-selank/.
Selank and Anxiety
Anxiety regulation is the most studied area of Selank research. In a clinical study involving 62 patients with generalized anxiety disorder (GAD) and neurasthenia, Selank was shown to induce anxiolytic effects comparable to the benzodiazepine medazepam. In addition to reducing anxiety symptoms, anti-asthenic and psychostimulant effects were also observed, helping participants maintain mental acuity and daily activity [4].
Laboratory studies suggest that Selank may influence anxiety regulation by acting as a positive allosteric modulator of GABA receptors. This mechanism bears some resemblance to the action of classic anxiolytic drugs, however, Selank appears to interact with the GABA system more selectively, which may explain its anxiolytic effect without pronounced sedation [1].
Animal studies further confirm these observations. Researchers have shown that Selank enhanced the anxiolytic effects of benzodiazepines while reducing some of their sedative and muscle-relaxant properties [5].
Selank and Stress Resistance
Chronic stress can disrupt neurotransmitter balance, immune system function, emotional regulation, and neuroplasticity. Several studies suggest that Selank may support the body in adapting to stress by influencing multiple biological systems involved in the stress response [1,2].
One of the proposed mechanisms is the protection of enkephalins – naturally occurring opioid peptides that play a significant role in mood regulation and stress adaptation. Researchers have demonstrated that Selank effectively inhibits enzymes responsible for enkephalin breakdown and exhibits a stronger effect than some reference compounds used in laboratory studies [6].
By maintaining the activity of endogenous enkephalins, Selank can support emotional stability and psychological resilience during periods of increased stress.
Selank as a Nootropic
Beyond its anxiolytic properties, Selank has gained interest as a potential nootropic peptide. Research suggests it may support learning processes, memory, cognitive efficiency, and mental performance, particularly in situations where stress or anxiety negatively impact cognitive functions [1,2].
Unlike stimulants that primarily act by increasing catecholamine release, Selank appears to interact with broader regulatory systems related to neuronal communication, adaptation, and neuroplasticity. For this reason, it is being studied as a peptide that supports cognitive functions while maintaining neurochemical balance [2,3].
Selank and Cognitive Functions
Several studies suggest that Selank may influence memory processes, information processing, and the ability of neurons to adapt by interacting with neurotrophic factors and cell signaling pathways.
In one study on the intranasal administration of Selank in rats, significant changes in the expression of brain-derived neurotrophic factor (BDNF) in the hippocampus were observed. Since BDNF plays a crucial role in learning, memory consolidation, synaptic plasticity, and long-term brain health, these results may partially explain the effects of Selank on cognitive functions [7].
Additional transcriptomic studies on Selank-related peptides have shown changes in the expression of genes associated with immune regulation, cell signaling, and neuronal adaptation following neurological damage [8].
Selank and Concentration
Many people are interested in Selank due to its potential to support concentration and mental productivity. Although there are few direct clinical studies evaluating attention and focus, there are several mechanisms that could explain such an effect.
Anxiety often impairs executive functions, working memory, and the ability to sustain attention. By supporting anxiety regulation without pronounced sedative effects, Selank may enable more efficient use of cognitive resources during task performance. The psychostimulant and anti-asthenic effects observed in clinical studies also support this hypothesis [4].
Selank for ADHD
Interest in Selank in the context of ADHD stems mainly from reports regarding its effects on attention, emotional regulation, and cognitive functions. However, there are currently no large-scale clinical trials evaluating Selank as a treatment for ADHD.
Researchers suggest that Selank's influence on neurotransmitter systems involved in attention and executive functions may partially explain the observed effects. However, further controlled studies are needed to draw definitive conclusions [1–3].
Selank and Dopamine
Dopamine plays a significant role in motivation, reward perception, concentration, and cognitive function. Research suggests that Selank may indirectly influence dopaminergic signaling through broader neurochemical regulation and neuropeptide activity.
Instead of acting as a direct agonist of dopamine receptors, Selank appears to function as a regulatory peptide that interacts with multiple neurotransmitter systems simultaneously. This mechanism may support mood, motivation, cognitive function, and emotional stability without overstimulation [1,2].
Selank and Serotonin
Serotonin participates in mood regulation, anxiety control, emotional processing, and overall mental well-being. Although Selank's best-known mechanism remains GABA system modulation, researchers believe its broader neuroregulatory effects may also influence serotonin-related pathways.
These interactions may partially explain the improvement in mood and emotional balance observed in experimental and clinical studies [1,2].
Selank a BDNF
One of the most interesting discoveries about Selank is its effect on brain-derived neurotrophic factor (BDNF). BDNF is essential for neuron growth, synaptic plasticity, learning processes, memory formation, and neuroprotection.
In experimental studies using intranasal administration, Selank was observed to regulate BDNF gene expression in the hippocampus. Since reduced BDNF activity is associated with stress, cognitive impairment, and limited neuroplasticity, this discovery has generated significant interest in the potential impact of Selank on long-term brain health [7].
Selank and Cortisol
Cortisol is one of the main stress hormones. Elevated cortisol levels are often associated with increased anxiety, impaired cognitive function, sleep problems, and reduced stress resilience.
There are few direct studies assessing the effect of Selank on cortisol levels; however, its documented impact on anxiety regulation, GABA activity, endogenous opioid peptides, and stress adaptation mechanisms suggests that it may indirectly influence the body's stress response [1,2,6].
Selank and Sen
Sleep quality plays a crucial role in cognitive functions, emotional regulation, and nervous system regeneration. Scientific reviews concerning Selank and related neuroregulatory peptides indicate potential benefits related to stress reduction and supporting nervous system balance, which may indirectly affect sleep quality [2].
By supporting emotional stability and reducing anxiety, Selank may create conditions conducive to restorative sleep. However, unlike classical sleeping pills, it does not appear to act primarily as a sleep-inducing substance [1,4].
Neuroprotective Properties of Selank
Research suggests that Selank possesses neuroprotective properties beyond simply supporting anxiety regulation. Experimental studies have demonstrated an influence on neurotrophic factors, immune signaling pathways, gene expression, and neuronal adaptation mechanisms.
The Pro-Gly-Pro fragment present in the Selank molecule may also contribute its own neuroprotective activity. Researchers suggest that this element not only increases the stability of the peptide but may also participate in neuronal protection and regeneration processes [8, 9].
Immune and Antiviral Activity
Since Selank was developed based on tuftsin, a natural immunomodulatory peptide, researchers also analyzed its impact on the functioning of the immune system.
Experimental studies have shown antiviral activity against several viral models and the ability of Selank-related peptides to stimulate interferon production. Further analyses have identified specific structural fragments responsible for antiviral activity, suggesting that Selank's action may extend beyond the nervous system [10].
Does Selank Actually Work?
Current scientific data indicate that Selank induces measurable biological effects in both human and animal studies. Clinical studies have shown anxiolytic effects comparable to some commonly used drugs, while mechanistic studies have confirmed its influence on GABA signaling, endogenous opioid peptide metabolism, neurotrophic factors, the immune system, and gene expression [1,4,6,7].
However, it should be noted that most research originates from Russia and Eastern Europe, and large international clinical trials are still lacking. While current results are promising, further randomized controlled trials are needed.
Summary
Research suggests that Selank may support anxiety regulation, stress resilience, cognitive function, emotional balance, neuroprotection, and overall brain health through various biological mechanisms. Its action appears to involve GABAergic signaling, endogenous opioid peptide pathways, neurotrophic factors like BDNF, immune regulation, and broader neurochemical modulation.
Despite promising results, further large-scale clinical trials are needed to fully assess Selank's therapeutic potential, its optimal uses, and its safety profile.
Disclaimer
This article is for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. Selank is not approved as a treatment for anxiety disorders, cognitive problems, ADHD, sleep disorders, or other conditions in many countries. Human studies are still limited, and further clinical trials are needed to fully assess its safety and efficacy.
For research purposes only: Selank products offered by Semax Polska are intended solely for laboratory and scientific research. They are not intended for human consumption or for medical, diagnostic, therapeutic, or preventive use. Researchers should use them in accordance with applicable laws, regulations, and scientific research standards.
References
[1] Vyunova, T. V., Andreeva, L. N., Shevchenko, K. V., & Myasoedov, N. F. (2018). Peptide-based anxiolytics: The molecular aspects of heptapeptide Selank biological activity. Protein and Peptide Letters, 25(10), 914-923. https://doi.org/10.2174/0929866525666180925144642
[2] Mechanisms of action and neurobiological effects of Selank and related regulatory peptides. Frontiers in Pharmacology, 7, Article 31. https://doi.org/10.3389/fphar.2016.00031
[3] PubChem. (2026). Selank (CID 11765600). National Center for Biotechnology Information. https://pubchem.ncbi.nlm.nih.gov/compound/Selank
[4] Zozulia, A. A., Neznamov, G. G., Syuniakov, T. S., Kost, N. V., Gabaeva, M. V., Sokolov, O. Y., Serebryakova, E. V., Siranchieva, O. A., Andryushchenko, A. V., Telesheva, E. S., Syuniakov, S. A., Smulevich, A. B., Myasoedov, N. F., & Seredenin, S. B. (2008). Efficacy and possible mechanisms of action of a new peptide anxiolytic Selank in the therapy of generalized anxiety disorders and neurasthenia. Journal of Neurology and Psychiatry named after S. S. Korsakov, 108(4), 38-48. https://pubmed.ncbi.nlm.nih.gov/18454096/
[5] Kost, N. V., Sokolov, O. Y., Zozulya, S. A., & Myasoedov, N. F. (2025). Combined action of benzodiazepine tranquilizers and peptide anxiolytic Selank in BALB/c mice. Neurochemical Journal, 19, 743–748. https://doi.org/10.1134/S1819712425700783
[6] Zozulya, A. A., Kost, N. V., Sokolov, O. Y., Gabaeva, M. V., Grivennikov, I. A., Andreeva, L. N., Zolotarev, Y. A., Ivanov, S. V., Andryushchenko, A. V., Myasoedov, N. F., & Smulevich, A. B. (2001). The inhibitory effect of Selank on enkephalin-degrading enzymes as a possible mechanism of its anxiolytic activity. Bulletin of Experimental Biology and Medicine, 131(4), 315-317. https://doi.org/10.1023/A:1017979514274
[7] Levitskaya, N. G., Andreeva, L. A., Nagaev, I. Y., Mezentseva, M. V., Shapoval, I. M., Podchernyaeva, R. Y., Shcherbenko, V. E., Potapova, L. A., Russu, L. I., Ershov, F. I., & Myasoedov, N. F. (2010). Intranasal administration of the peptide Selank regulates BDNF expression in the rat hippocampus in vivo. Doklady Biological Sciences, 431, 79–82. https://www.researchgate.net/publication/23306196_Intranasal_administration_of_the_peptide_Selank_regulates_BDNF_expression_in_the_rat_hippocampus_in_vivo
[8] Medvedeva, E. V., Dmitrieva, V. G., Povarova, O. V., Limborskaia, S. A., Skvortsova, V. I., Miasoedov, N. F., & Dergunova, L. V. (2014). Effect of tripeptide Pro-Gly-Pro on rat brain transcriptome in focal ischemia. Molecular Biology (Moscow), 48(2), 277–287. PMID: 25850296.
[9] Andreeva, L. A., Nagaeva, I. Y., Mezentseva, M. V., Shapoval, I. M., Podchernyaeva, R. Y., Shcherbenko, V. E., Potapova, L. A., Russu, L. I., Ershov, F. I., & Myasoedov, N. F. (2010). Antiviral properties of structural fragments of the peptide Selank. Doklady Biological Sciences, 431, 79–82. https://doi.org/10.1134/S0012496610020031
[10] Czabak-Garbacz, R., Cygan, B., Wolański, Ł., & Kozlovsky, I. (2006). Influence of long-term treatment with tuftsin analogue TP-7 on anxiety-phobic states and body weight. Pharmacological Reports, 58(4), 562–567. PMID: 16963804.